We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+18.55%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$329M
AUM Growth
+$66.1M
Cap. Flow
+$21.8M
Cap. Flow %
6.63%
Top 10 Hldgs %
35.2%
Holding
389
New
50
Increased
46
Reduced
77
Closed
42

Sector Composition

Rank Sector Weight
1 Technology 25.61%
2 Miscellaneous 15.39%
3 Healthcare 14.63%
4 Consumer Staples 14.04%
5 Financials 10.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MO icon
26
Altria Group
MO
$115B
$3.53M 1.07%
90,002
+1,282
+1% +$50K
FNV icon
27
Franco-Nevada
FNV
$51.3B
$3.29M 1%
+23,591
New +$3.13M
TFX icon
28
Teleflex
TFX
$5.92B
$3.19M 0.97%
8,750
-125
-1% -$43.2K
XSLV icon
29
Invesco S&P SmallCap Low Volatility ETF
XSLV
$245M
$3.04M 0.92%
89,943
+18,597
+26% +$618K
PM icon
30
Philip Morris
PM
$299B
$3.03M 0.92%
43,215
+821
+2% +$59.9K
KO icon
31
Coca-Cola
KO
$386B
$2.89M 0.88%
64,661
SYK icon
32
Stryker
SYK
$127B
$2.88M 0.87%
15,955
-650
-4% -$120K
SYBT icon
33
Stock Yards Bancorp
SYBT
$2.48B
$2.87M 0.87%
71,436
+3,988
+6% +$130K
VRTX icon
34
Vertex Pharmaceuticals
VRTX
$137B
$2.87M 0.87%
9,888
+13
+0.1% +$3.52K
ADP icon
35
Automatic Data Processing
ADP
$114B
$2.8M 0.85%
18,809
-175
-0.9% -$25.1K
WY icon
36
Weyerhaeuser
WY
$17B
$2.74M 0.83%
122,085
-12,335
-9% -$250K
RMD icon
37
ResMed
RMD
$34.7B
$2.66M 0.81%
13,842
HCI icon
38
HCI Group
HCI
$2.32B
$2.54M 0.77%
+54,975
New +$2.38M
EL icon
39
Estee Lauder
EL
$37.4B
$2.18M 0.66%
11,565
+5
+0% +$893
TRP icon
40
TC Energy
TRP
$64.4B
$2.16M 0.65%
50,304
USB.PRM
41
DELISTED
U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul
USB.PRM
$2.01M 0.61%
77,010
-250
-0.3% -$6.66K
ROP icon
42
Roper Technologies
ROP
$42.2B
$1.99M 0.61%
5,137
-6
-0.1% -$2.15K
TD icon
43
Toronto Dominion Bank
TD
$199B
$1.97M 0.6%
44,104
MRK icon
44
Merck
MRK
$366B
$1.86M 0.56%
25,173
-131
-0.5% -$9.86K
BIIB icon
45
Biogen
BIIB
$32.3B
$1.85M 0.56%
6,930
EW icon
46
Edwards Lifesciences
EW
$52B
$1.8M 0.55%
+26,082
New +$1.85M
NVO
47
Novo Nordisk
NVO
$202B
$1.7M 0.51%
51,786
-264
-0.5% -$8.43K
GOOG icon
48
Alphabet (Google) Class C
GOOG
$4.19T
$1.69M 0.51%
23,900
+3,260
+16% +$220K
LQD icon
49
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
$1.64M 0.5%
12,160
-150
-1% -$19.5K
ET icon
50
Energy Transfer Partners
ET
$73.4B
$1.55M 0.47%
217,710
+46,678
+27% +$346K

Similar funds

American Research & Management Company's Q2 2020 Portfolio in Review

As of Q2 2020, American Research & Management Company held 389 positions worth $329M, up 25% from $263M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

American Research & Management Company deployed $21.8M of net new capital in Q2 2020, opening 50 new positions and adding to 46 existing holdings. Its largest new stake was iShares Gold Trust: 427,850 shares worth $14.5M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was RTX Corp, an estimated $1.69M trimmed.

  • American Research & Management Company's largest Q2 2020 buy was iShares Gold Trust: 427,850 shares worth $14.5M.
  • American Research & Management Company added most to Invesco S&P SmallCap Low Volatility ETF in Q2 2020, an estimated $618K increase.
  • American Research & Management Company's biggest Q2 2020 reduction was RTX Corp, cutting an estimated $1.69M.
  • American Research & Management Company fully exited American Coastal Insurance in Q2 2020, selling an estimated $2.22M.
  • American Research & Management Company's ten largest holdings make up 35% of its $329M portfolio in Q2 2020.
  • American Research & Management Company opened 50 new positions and closed 42 in Q2 2020.
  • American Research & Management Company's portfolio value rose 25% quarter-over-quarter to $329M.

Based on American Research & Management Company's 13F filing for Q2 2020, filed 28 Jul 2020.